These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25765509)

  • 21. Chemical applicability domain of the local lymph node assay (LLNA) for skin sensitisation potency. Part 4. Quantitative correlation of LLNA potency with human potency.
    Roberts DW; Api AM
    Regul Toxicol Pharmacol; 2018 Jul; 96():76-84. PubMed ID: 29730445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyldibromoglutaronitrile: skin sensitization and quantitative risk assessment.
    Basketter DA
    Cutan Ocul Toxicol; 2010 Mar; 29(1):4-9. PubMed ID: 19883218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of skin sensitisation potential.
    Roberts DW; Aptula AO
    J Appl Toxicol; 2008 Apr; 28(3):377-87. PubMed ID: 17703504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Categorization of chemicals according to their relative human skin sensitizing potency.
    Basketter DA; Alépée N; Ashikaga T; Barroso J; Gilmour N; Goebel C; Hibatallah J; Hoffmann S; Kern P; Martinozzi-Teissier S; Maxwell G; Reisinger K; Sakaguchi H; Schepky A; Tailhardat M; Templier M
    Dermatitis; 2014; 25(1):11-21. PubMed ID: 24407057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
    Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hazard identification of strong dermal sensitizers.
    Gould JC; Taylor S
    Toxicol Mech Methods; 2011 Feb; 21(2):86-92. PubMed ID: 20500014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019.
    Basketter D; Beken S; Bender H; Bridges J; Casati S; Corvaro M; Cuvellier S; Hubesch B; Irizar A; Jacobs MN; Kern P; Lamplmair F; Manou I; Müller BP; Roggeband R; Rossi LH
    Regul Toxicol Pharmacol; 2020 Nov; 117():104767. PubMed ID: 32866543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of selected valid and mechanistically based SARs for skin sensitisation.
    Fabjan E; Hulzebos E
    Toxicol In Vitro; 2008 Mar; 22(2):468-90. PubMed ID: 18494147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.
    Basketter D; Kimber I
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):524-8. PubMed ID: 24893346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency.
    Kimber I; Maxwell G; Gilmour N; Dearman RJ; Friedmann PS; Martin SF
    Toxicology; 2012 Jan; 291(1-3):18-24. PubMed ID: 22120538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of non-covalent protein binding in skin sensitisation potency of chemicals.
    Aleksic M; Thain E; Gutsell SJ; Pease CK; Basketter DA
    Cutan Ocul Toxicol; 2007; 26(2):161-9. PubMed ID: 17612982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
    Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
    Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a systems biology approach to skin allergy risk assessment.
    Maxwell G; Mackay C
    Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preservatives and skin sensitization quantitative risk assessment.
    Basketter DA; Clapp CJ; Safford BJ; Jowsey IR; McNamee P; Ryan CA; Gerberick GF
    Dermatitis; 2008; 19(1):20-7. PubMed ID: 18346392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reference Chemical Potency List (RCPL): A new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs).
    Irizar A; Bender H; Griem P; Natsch A; Vey M; Kimber I
    Regul Toxicol Pharmacol; 2022 Oct; 134():105244. PubMed ID: 35932886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential.
    Roberts DW; Aptula AO; Patlewicz G; Pease C
    J Appl Toxicol; 2008 May; 28(4):443-54. PubMed ID: 17703503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.